Skip to main content
. 2020 Mar 4;10(10):4308–4322. doi: 10.7150/thno.41322

Figure 3.

Figure 3

(A) The size of formulations in 50% FBS over time. (B) The variation in turbidity (represented by transmittance) of formulations in 50% FBS (n=3, mean ±SD). (C) The in vitro release profiles of formulations in PBS (n=3, mean ±SD).